相关实验视频

Updated: Sep 14, 2025

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

从网络预测到实验验证:Artemisia absinthium L.精油 (AAEO) 对抗抑郁症的多目标机制

Zhihao Liu¹, Qixin Wang², Xiaolin Li³

¹State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China; National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; College of Chemistry and Chemical Engineering, Qinghai Minzu University, Xining, 810007, China.

Journal of ethnopharmacology

|July 20, 2025

概括

阿尔特米西亚卜辛L精油 (AAEO) 通过向GABAergic和血清激素系统,显示抗抑郁作用. 这项研究验证了传统的用途,并建议AAEO作为情绪障碍的潜在植物治疗药物.

科学领域:

植物化学和药理学
神经科学与自然产品

背景情况:

树 (Artemisia absinthium L.) 具有历史性的民族医学用途,用于神经调节和情绪.
传统应用表明潜在的抗抑郁药物特性,但缺乏机理学研究.

研究的目的:

调查Artemisia absinthium L.精油 (AAEO) 对抗抑郁作用的多目标机制.
将传统知识与AAEO神经镇静性质的现代药理学验证相结合.

主要方法:

气相色谱-质谱 (GC-MS) 用于AAEO组成分析.
网络药理学,分子对接和动态模拟来预测和验证目标.
在慢性不可预测的轻度压力 (CUMS) 诱导的小鼠体内研究和在皮质受损的PC12细胞体内测试.

主要成果:

AAEO主要含有类和类,其中alpha-thujone,linalyl phenylacetate和mansonone C被确定为关键化合物.
这些化合物对GABAergic (GABRA2,GABRB3) 和 serotonergic (SLC6A4,MAOB) 标具有强烈的结合亲和力.
AAEO在体内表现出显著的抗抑郁作用,在体内表现出显著的细胞保护作用,其中GABRB3和SLC6A4发挥了关键作用.

结论:

通过对GABAergic (GABRB3) 和 serotonergic (SLC6A4) 系统的协同作用,AAEO具有抗抑郁作用.
机械验证支持Artemisia absinthium L.在情绪调节方面的传统使用.
AAEO是一种有前途的多目标植物疗法候选人,用于抑郁症.

关键词:

亚瑟米西亚青植物L.阿瑟米西亚青植物L.抑郁症抑郁症抑郁症精油精油精油精油网络药理学网络药理学

更多相关视频

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Depressants

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...